Aclaris Therapeutics, Inc. (ACRS)
6.31
-0.10
(-1.56%)
USD |
NASDAQ |
Aug 24, 16:00
6.40
+0.09
(+1.43%)
After-Hours: 06:35
Aclaris Therapeutics Price : 6.31 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 6.35 | 6.40 | 6.02 | 6.31 | 1.273M |
| Aug 21, 2026 | 6.36 | 6.50 | 6.29 | 6.41 | 2.208M |
| Aug 20, 2026 | 6.35 | 6.46 | 6.17 | 6.33 | 1.515M |
| Aug 19, 2026 | 6.40 | 6.449 | 6.20 | 6.44 | 2.065M |
| Aug 18, 2026 | 5.88 | 6.315 | 5.854 | 6.305 | 2.013M |
| Aug 17, 2026 | 5.72 | 5.955 | 5.685 | 5.92 | 1.086M |
| Aug 14, 2026 | 5.82 | 5.855 | 5.64 | 5.78 | 666269.0 |
| Aug 13, 2026 | 5.90 | 6.055 | 5.812 | 5.86 | 1.066M |
| Aug 12, 2026 | 5.94 | 5.97 | 5.84 | 5.84 | 937109.0 |
| Aug 11, 2026 | 5.90 | 5.935 | 5.80 | 5.92 | 1.210M |
| Aug 10, 2026 | 5.92 | 5.99 | 5.67 | 5.90 | 1.594M |
| Aug 07, 2026 | 6.08 | 6.23 | 5.65 | 5.91 | 2.388M |
| Aug 06, 2026 | 6.34 | 6.44 | 5.90 | 6.09 | 2.822M |
| Aug 05, 2026 | 5.99 | 6.515 | 5.91 | 6.36 | 5.676M |
| Aug 04, 2026 | 5.63 | 6.045 | 5.59 | 5.98 | 2.577M |
| Aug 03, 2026 | 5.19 | 5.55 | 5.010 | 5.53 | 1.952M |
| Jul 31, 2026 | 5.30 | 5.34 | 5.095 | 5.20 | 1.638M |
| Jul 30, 2026 | 5.13 | 5.43 | 5.01 | 5.32 | 1.905M |
| Jul 29, 2026 | 5.34 | 5.35 | 5.050 | 5.12 | 1.178M |
| Jul 28, 2026 | 5.34 | 5.365 | 5.18 | 5.33 | 1.553M |
| Jul 27, 2026 | 5.29 | 5.615 | 5.20 | 5.37 | 4.860M |
| Jul 24, 2026 | 5.52 | 5.54 | 5.21 | 5.23 | 760682.0 |
| Jul 23, 2026 | 5.51 | 5.62 | 5.365 | 5.48 | 879818.0 |
| Jul 22, 2026 | 5.69 | 5.69 | 5.51 | 5.62 | 963921.0 |
| Jul 21, 2026 | 5.55 | 5.69 | 5.46 | 5.69 | 1.359M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 123.24 |
| Nektar Therapeutics | 73.69 |
| Xeris Biopharma Holdings, Inc. | 8.74 |
| Crinetics Pharmaceuticals, Inc. | 84.78 |
| Alumis, Inc. | 23.03 |
Price Related Metrics
| PS Ratio | 99.20 |
| Price to Book Value | 7.082 |
| Earnings Yield | -9.27% |
| Market Cap | 882.29M |